drugset / Trial / NCT05327088

Epidural Dexmedetomidine vs Nalbuphine for Labor Analgesia

NCT05327088

Phase 2 Completed 64 enrolled Ain Shams University
RandomizedParallel-groupSingle-blindTreatment

Summary

The aim of this study is to compare epidural dexmedetomidine vs nalbuphine added to bupivacaine in labor analgesia and determine the privilege of one over the other and to compare the effect of both analgesics after delivery.

Timeline

Start
2021-09-12
Primary completion
2022-02-12
Completion
2022-03-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 0.5 ug/ml Other
Comparator Nalbuphine Small molecule 2 mg Other

Indications

No indication recorded.